PDS Biotechnology (Germany) Buy Hold or Sell Recommendation
| EU6 Stock | EUR 1.67 0.09 5.70% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding PDS Biotechnology Corp is 'Strong Sell'. Macroaxis provides PDS Biotechnology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EU6 positions.
Check out PDS Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as PDS and provide practical buy, sell, or hold advice based on investors' constraints. PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
PDS |
Execute PDS Biotechnology Buy or Sell Advice
The PDS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on PDS Biotechnology Corp. Macroaxis does not own or have any residual interests in PDS Biotechnology Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute PDS Biotechnology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
PDS Biotechnology Trading Alerts and Improvement Suggestions
| PDS Biotechnology generated a negative expected return over the last 90 days | |
| PDS Biotechnology may become a speculative penny stock | |
| PDS Biotechnology has high historical volatility and very poor performance | |
| PDS Biotechnology has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (16.92 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PDS Biotechnology Corp has accumulated about 74.75 M in cash with (12.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 14.0% of the company shares are held by company insiders |
PDS Biotechnology Returns Distribution Density
The distribution of PDS Biotechnology's historical returns is an attempt to chart the uncertainty of PDS Biotechnology's future price movements. The chart of the probability distribution of PDS Biotechnology daily returns describes the distribution of returns around its average expected value. We use PDS Biotechnology Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of PDS Biotechnology returns is essential to provide solid investment advice for PDS Biotechnology.
| Mean Return | -0.6 | Value At Risk | -8.81 | Potential Upside | 6.43 | Standard Deviation | 5.81 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of PDS Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
PDS Biotechnology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to PDS Biotechnology or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that PDS Biotechnology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a PDS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.61 | |
β | Beta against Dow Jones | 0.04 | |
σ | Overall volatility | 4.85 | |
Ir | Information ratio | -0.11 |
PDS Biotechnology Volatility Alert
PDS Biotechnology Corp exhibits very low volatility with skewness of 0.9 and kurtosis of 3.58. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure PDS Biotechnology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact PDS Biotechnology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.PDS Biotechnology Fundamentals Vs Peers
Comparing PDS Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PDS Biotechnology's direct or indirect competition across all of the common fundamentals between PDS Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as PDS Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of PDS Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing PDS Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PDS Biotechnology to competition |
| Fundamentals | PDS Biotechnology | Peer Average |
| Return On Equity | -0.49 | -0.31 |
| Return On Asset | -0.25 | -0.14 |
| Current Valuation | 189.69 M | 16.62 B |
| Shares Outstanding | 28.89 M | 571.82 M |
| Shares Owned By Insiders | 14.20 % | 10.09 % |
| Shares Owned By Institutions | 23.77 % | 39.21 % |
| Price To Earning | 23.42 X | 28.72 X |
| Price To Book | 5.63 X | 9.51 X |
| EBITDA | (21.43 M) | 3.9 B |
| Net Income | (16.92 M) | 570.98 M |
| Cash And Equivalents | 74.75 M | 2.7 B |
| Cash Per Share | 2.63 X | 5.01 X |
| Total Debt | 552.98 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 19.22 X | 2.16 X |
| Book Value Per Share | 1.65 X | 1.93 K |
| Cash Flow From Operations | (12.49 M) | 971.22 M |
| Earnings Per Share | (0.91) X | 3.12 X |
| Price To Earnings To Growth | (0.29) X | 4.89 X |
| Target Price | 19.71 | |
| Number Of Employees | 22 | 18.84 K |
| Beta | 1.91 | -0.15 |
| Market Capitalization | 206 M | 19.03 B |
| Total Asset | 67.2 M | 29.47 B |
| Net Asset | 67.2 M |
PDS Biotechnology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as PDS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 1.67 | |||
| Day Typical Price | 1.67 | |||
| Price Action Indicator | 0.045 | |||
| Period Momentum Indicator | 0.09 |
About PDS Biotechnology Buy or Sell Advice
When is the right time to buy or sell PDS Biotechnology Corp? Buying financial instruments such as PDS Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having PDS Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Sovereign ETFs Thematic Idea Now
Broad Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Sovereign ETFs theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in PDS Stock
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out PDS Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.